HomeCBI • TLV
add
Clal Biotechnology Industries Ltd.
Previous close
ILA 30.30
Day range
ILA 30.80 - ILA 31.00
Year range
ILA 26.10 - ILA 44.00
Market cap
48.47M ILS
Avg Volume
56.62K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
| (ILS) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 5.77M | — |
Operating expense | 1.12M | -26.27% |
Net income | -1.48M | 85.99% |
Net profit margin | -25.71 | — |
Earnings per share | — | — |
EBITDA | 4.70M | 441.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (ILS) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.69M | -66.29% |
Total assets | 41.83M | -38.20% |
Total liabilities | 18.95M | -11.95% |
Total equity | 22.88M | — |
Shares outstanding | 148.12M | — |
Price to book | 2.16 | — |
Return on assets | 27.82% | — |
Return on capital | 28.76% | — |
Cash Flow
Net change in cash
| (ILS) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.48M | 85.99% |
Cash from operations | -911.50K | 44.59% |
Cash from investing | 1.02M | -40.84% |
Cash from financing | -69.50K | 95.30% |
Net change in cash | 41.00K | 102.94% |
Free cash flow | 2.74M | 391.00% |
About
Founded
1998
Website
Employees
3
